WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Innoviva earnings were $193.4M for the trailing 12 months ending Sep 30, 2026, with 43.9% growth year over year. The latest INVA earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$73.9M, down 11.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INVA reported annual earnings of $271.2M, with 1,059.2% growth.

INVA past earnings growth

How has INVA's earnings growth performed historically?

Company
43.92%
Industry
38.99%
Market
91.66%
INVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
INVA's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

INVA earnings history

Current Revenue
$438.3M
Current Earnings
$193.4M
Current Profit Margin
44.1%
INVA's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

INVA Return on Equity

Current Company
15.8%
Current Industry
-8.8%
Current Market
35.3%
INVA's Return on Equity (15.8%)... subscribe to Premium to read more.
High Return on Equity Performance

INVA Return on Assets

Current Company
11.5%
Current Industry
3.5%
INVA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INVA announces earnings.

INVA Return on Capital Employed

Current Company
16.38%
Current Industry
6.9%
INVA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INVA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INVA$284.21M$193.44M-4.97%$2.72
MLYS-$366.75M-$369.97MN/A-$4.31
LBRX-$140.52M-$141.20MN/A-$1.04
ANAB$16.61M$195.72MN/A$6.76
TSHA-$147.15M-$149.63MN/A-$0.42
View Top Biotech Stocks

Innoviva Earnings Reports & History FAQ

What were Innoviva's earnings last quarter?

On INVA's earnings call on Nov 4, 2026, Innoviva (NASDAQ: INVA) reported Q3 2026 earnings per share (EPS) of -$1.03, up 179.23% year over year. Total INVA earnings for the quarter were -$73.89 million. In the same quarter last year, Innoviva's earnings per share (EPS) was $1.30.

If you're new to stock investing, here's how to buy Innoviva stock.

Is Innoviva profitable or losing money?

As of the last Innoviva earnings report, Innoviva is currently profitable. Innoviva's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $193.44 million, a 51.9% increase year over year.

What was INVA's earnings growth in the past year?

As of Innoviva's earnings date in Nov 4, 2026, Innoviva's earnings has grown 43.92% year over year. This is 4.92 percentage points higher than the US Biotechnology industry earnings growth rate of 38.99%. INVA earnings in the past year totalled $193.44 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.